DIA 2013 49th Annual Meeting
Click here to go to the previous page
Convergence in Regulatory Science Across the Strait
Track : Track 18: Global Regulatory
Program Code: 261
Date: Tuesday, June 25, 2013
Time: 1:45 PM to 3:15 PM  EST
Location: 253B
CHAIR :
 Ning Li, MD,PhD (SPKNON), Vice President, GRA Head, Medical Policy, Asia, Sanofi, China
SPEAKER (S):
 Ling Su, PhD (SPKNON), Strategic Advisor, Life Sciences, Sidley Austin LLP, China
Mey Wang, PhD (SPKAGY), Reviewer, Division of New Drugs, Center for Drug Evaluation, Taiwan
Zhen Chen, PhD (SPKAGY), Deputy Office Director, Office of New Drug Pharmaceutical Science, Center for Drug Evaluation of CFDA, China
Hsin-Jung Lee, (SPKAGY), Reviewer, Division of New Drugs, Center for Drug Evaluation, Taiwan
 Yi Feng, (SPKAGY), Office of Evaluation Management and Communication, Center for Drug Evaluation of CFDA, China
Description
In this forum, representatives from the Center of Drug Evaluation from mainland China and the Center for Drug Evaluation from Taiwan will share their views and experience in Good Review Practice (GRP) and IND review. This will form the basis for the discussion of collaboration opportunities and areas of convergence in regulatory science in the two centers.